贝瑞基因：控股股东高扬先生累计被强制执行353.52万股

Core Viewpoint - The announcement reveals that the controlling shareholder of Berry Genomics, Mr. Gao Yang, has defaulted on a stock pledge repurchase agreement, leading to a court-ordered forced liquidation of his shares in the company [1] Group 1: Shareholder Actions - Mr. Gao Yang is subject to a court ruling that mandates the forced liquidation of up to 3.5352 million shares of Berry Genomics, which represents no more than 1% of the company's total share capital [1] - The forced execution deadline is set for July 10, 2025, indicating a timeline for the liquidation process [1] Group 2: Shareholding Changes - Following the forced execution, Mr. Gao Yang and his concerted party, Ms. Hou Ying, have seen their combined shareholding decrease from 11.99% to 11.95% of the total share capital, reflecting a change of 0.04% due to the forced execution [1] - The shares are to be executed at a price range of 12.59 to 14.84 yuan per share, which provides insight into the potential market impact of the forced sale [1]